Melanoma trials in Lithuania

3 of 3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  A PK study to compare JPB898 (proposed nivolumab biosimilar) and US-licensed Opdivo® in participants with resected stage IIB, IIC, or III melanoma in the adjuvant setting

  Where

  Kaunas, Vilnius

  Age

  18 years and over

  People

  89 worldwide

  Run by

  H e x a l AG

  See details and how to join2025-521919-39-00 · EU 2025-521919-39-00
• Phase 3Taking people
  Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma

  Where

  Vilnius

  Age

  18 years and over

  People

  1,792 worldwide

  Run by

  Uppsala University

  See details and how to joinNCT06488482 · EU 2023-509994-22-00
• Phase 3Taking people
  IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

  Where

  Kaunas, Vilnius

  Age

  18 years and over

  People

  680 worldwide

  Run by

  Immunocore Ltd

  See details and how to joinNCT06112314